Skip to Main Content

Contribute Try STAT+ Today

antibiotics

Most Read

bacteria SOS antimicrobial resistance

First Opinion By Sevahn Vorperian and Stephen Quake

The PASTEUR Act can help win the war against superbugs

prescription pill illo

First Opinion By David Hyun and Rachel Zetts

Many hospitalized Covid-19 patients are given antibiotics. That’s a problem

antibiotics/teal background

Pharmalot By Ed Silverman

Pharma’s ambitious new antibiotic venture hires a CEO to fix a ‘broken’ pipeline

pill head antibiotics

First Opinion By Jowa (Zhuo) Shi and Ateev Mehrotra

Inappropriately prescribed antibiotics will likely accompany the winter surge of Covid-19

Streptococcus Pneumoniae antibiotic resistance

First Opinion By Julie L. Gerberding

Antibiotic resistance: the hidden threat lurking behind Covid-19

Candida auris fungi

Health By Helen Branswell

The superbug Candida auris is giving rise to warnings — and big questions

C. Auris

Health By Helen Branswell

Patients with feared superbug shed large amounts of it from their skin, study says

MRSA

First Opinion By Thomas B. Cueni

Creating new antimicrobial drugs will require governments working with industry

All Coverage

antibiotics

First Opinion By Natalie Ma

My company is developing new antibiotics. My resistant infection showed me we need them now

antimicrobial resistance

First Opinion By Kevin Outterson

In the calm before the superbug storm, the world needs to prepare

advertisement

Pharmalot By Ed Silverman

Older Americans bore the brunt of antibiotic-resistant infections, study finds

Brian Murphy

In the Lab By Peter Andrey Smith

In the hunt for novel antibiotics, will new technology overtake underwater exploration?

Pharma By Ed Silverman

STAT+ Conversations: the revitalization of the antibiotic drug pipeline

antibiotics - Pills and capsules

Pharma By Ed Silverman

Drug-resistant bacteria pose a growing threat. Can new antibiotics be developed fast enough to combat them?

CO Senator Michael Bennet

Pharmalot By Ed Silverman

Lawmakers revive legislation to accelerate the development of new antibiotics

pill shopping cart

Opinions+ By Peter Bak

Investment in antimicrobials was up in 2020, but much work remains

Antibiotic Incentives

Pharmalot By Ed Silverman

WHO warns the world is still failing to develop desperately needed antibiotics

First Opinion Podcast

First Opinion Podcast By Patrick Skerrett

Listen: Antibiotic experts on the threat of antimicrobial resistant superbugs

Pharmalot By Ed Silverman

EPA rule that could help citrus growers is challenged over concerns about antibiotic resistance

antibiotics/teal background

Pharmalot By Ed Silverman

Antibiotic stewardship may be improving at U.S. hospitals, but new targets are still needed

broken pill

Pharmalot By Ed Silverman

Antibiotic prescribing during the pandemic raises concern about drug resistance

Hospital Superbug Outbreak

First Opinion By Michelle McMurry-Heath

The Biden administration’s pandemic agenda must not ignore superbugs

Bill Cassidy w/ reporters

Politics By Matthew Herper

Sen. Cassidy explains why he’s backing a bill aimed at drug-resistant bacteria

Health By Matthew Herper and Ed Silverman

Virtual Event: Facing the crisis of drug-resistant germs

antibiotics/teal background

Pharmalot By Ed Silverman

New bill would create a subscription payment model to jumpstart antibiotic development

Pharmalot By Ed Silverman

Doctors say antibiotic resistance is an issue — but most say they’re not part of the problem

superbug

First Opinion By Kevin Outterson and John Rex

We need new antimicrobials to prevent the next infectious disease crisis

Penicillium

Special Report By Gardiner Harris and Alex W. Palmer — The Wire

China has near-total control of the world’s antibiotic supply. Is America at risk as a result?

antibiotics/teal background

First Opinion By Isaac Stoner

Saving lives should be good business. Why doesn’t that apply to finding new antibiotics?

Carbapenem-resistant, Acinetobacter

Pharmalot By Ed Silverman

WHO adviser says an antimicrobial fund can help a market that ‘needs to be fixed’

Pharmalot By Ed Silverman

Pharmalittle: France indicts Sanofi over epilepsy drug risks; Trump talk of drug pricing in SOTU speech may backfire

Antibiotic Pollution

First Opinion By Alba Tiley and Steve Brooks

Companies must responsibly manufacture the antimicrobials society needs

Antibiotic pills - pharmacy

First Opinion By Allan Coukell

Antibiotics need a special place in the drug pricing debate